Michael MacManus
@MP_MacManus
Followers
411
Following
975
Media
106
Statuses
363
Radiation Oncologist, Researcher, aspiring musician. all views my own
Melbourne, Victoria
Joined December 2018
Epitaph on a Tyrant Perfection, of a kind, was what he was after,……, He knew human folly like the back of his hand……. When he laughed, respectable senators burst with laughter, And when he cried the little children died in the streets. WH Auden (Apologies for the edits)
0
0
1
Check this out! 😃 Clinical-research #fellowships in radiation oncology at @PeterMacCC 🇦🇺 Apply here ➡️ https://t.co/xi6fZsKgCW
1
10
11
Amazing data on KV minibeam treatments at Mayo Clinic presented at MMND-ITRO in Sydney. Fantastic local and abscopal responses in patients with highly resistant tumours! Encouraging for pursuing MRT research at Australian Synchrotron! @ausynchrotron @MayoClinic @PeterMacRadOnc
1
2
6
Our congrats to Dr Fiona Hegi-Johnson, recipient of the George Hodgson Memorial Award.👏👏👏 Supported by the Peter MacCallum Cancer Foundation, the award funds a #radonc /radiobiol researcher @PeterMacCC to attend the Lorne Cancer Conference. @HegiFiona @PeterMacCC @PeterMacRes
3
1
12
@TROGfightcancer @CancerVic First RCT to show advantage for RT plus systemic therapy vs RT alone in early stage low-grade follicular lymphoma. In addition to improved PFS also showed significant improvement in composite endpoint of risk of death or transformation to aggressive lymphoma.
0
0
1
Thanks to @TROGfightcancer and @CancerVic for their support for the trial.
1
0
2
Hot off press in Lancet eBioMedicine, Final outcome data for TROG 99.03 with amazing translational data from Gandhi lab. https://t.co/V54OZFaU7z Rituximab and CD8 TCell status govern prognosis. Check out panel E! RT plus R a new standard of care? @PeterMacCC @PeterMacRadOnc
3
6
15
Terrific session on multimodality therapy in NSCLC at #wclc2024 Tantalising signals on potential role of induction chemoimmunotherapy before ChemoRT and even chemoimmunoRT before surgery. Thanks to discussant @gerryhanna for bringing clarity to a complex set of abstracts!
0
1
13
Great presentation by @HegiFiona at the presidential session at #wclc2025 Compelling case for following best practice in lung cancer radiotherapy in clinical trials of radiation and systemic therapies. Timely staging and RT planning with PET, concurrent chemo and RT QA critical.
0
3
13
Great discussion at #WCLC24 by Dr Chee Lee of really exciting early phase data from studies of 2 new TKIs with activity in HER2 mutant NSCLC. High response rates and acceptable toxicity.
0
1
7
In this new article from @MP_MacManus, Dose-response relationships between radiation exposure, bone marrow function as measured by 18F-FLT PET, and lymphocyte counts during chemoradiation for non-small cell lung cancer. Read here in the #RedJournal: https://t.co/2N7FHKS817
1
5
21
Our phenomenal #radonc team!! A superbly productive and energising day of aspirations and strategic planning @PeterMacRadOnc
#thefutureisbright 😎 @PeterMacCC @svporceddu
3
7
43
My bet is we need smarter #RT...immunotherapy can only go so far if the #NSCLC #radonc is shutting down the immune system....time to think of new ways to skin this old cat...@MP_MacManus @gerryhanna @sueyom @TommyJohn00 @harr
Press Release PACIFIC2: Ph III Trial Concurrent + consolidation durva+cCRT in stage III NSCLC No PFS Benefit ?Suggests timing of IO in relation to RT matters *PACIFIC 'picked the winners' of those who completed cCRT *These trials include diff grps of pts
1
2
11
Where in the world could you find such a beautiful and uncrowded tropical beach as Port Douglas?
0
0
6
✨From our latest issue✨ 📢Lung shielding blocks significantly reduced mean lung doses in patients undergoing total body irradiation for haematological malignancies @petalonski @MP_MacManus @belinda_campbe et al https://t.co/yJgcZBUOVu
onlinelibrary.wiley.com
Introduction Total body irradiation (TBI) practices vary considerably amongst centres, and the risk of treatment related toxicities remains unclear. We report lung doses for 142 TBI patients who...
0
4
7
Well done & thank you to Dr Peta Lonski who led this project.👏 Peta is a super talented member of our #radphys team @PeterMacRadOnc & a truly fabulous colleague. So thankful to work with you, @petalonski! ⭐️ #womenwhocurie @PeterMacCC @JMIRO_Journal @WomenInLymphoma @MP_MacManus
#EarlyView: Lung doses in patients undergoing total body irradiation for haematological malignancies with/without lung shielding 👉🏼Lung shielding blocks significantly reduced mean lung doses @PeterMacRadOnc @petalonski @MP_MacManus @belinda_campbe et al https://t.co/vLd3dp1odn
2
5
15
Congrats to Dr Mary Xu for her excellent work! Favourable outcomes from active surveillance of asymptomatic RT-induced meningiomas in #childhoodcancer #survivors. Free access to 19 Nov, thanks to @RadiotherapyOn1 🙏 https://t.co/RqYsfbyO7L
@PeterMacCC @RANZCRcollege @svporceddu
3
5
24
In the TARGET-TP RCT of biomarker driven thromboprophylaxis for adults w/cancer, thromboembolism (8% vs 23%) & death (13% vs 26%) were substantially reduced among those w/high-risk biomarker profiles receiving enoxaparin vs no thromboprophylaxis. https://t.co/2fFIZZun1A
0
5
7